| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | SP24YIT5YZ |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Tyrosine-protein kinase receptor FLT3 agonist |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 1 | D020522 | ClinicalTrials |
| Stomach Neoplasms | 1 | D013274 | ClinicalTrials |
| Esophageal Neoplasms | 1 | D004938 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
| Lung Neoplasms | 1 | D008175 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
| Lymphoma | 1 | D008223 | ClinicalTrials |
| Cholangiocarcinoma | 1 | D018281 | ClinicalTrials |
| Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4650387 |
| FDA SRS | SP24YIT5YZ |
CONTENTS